Cargando…
Myocardial fibrosis reversion via rhACE2-electrospun fibrous patch for ventricular remodeling prevention
Myocardial fibrosis and ventricular remodeling were the key pathology factors causing undesirable consequence after myocardial infarction. However, an efficient therapeutic method remains unclear, partly due to difficulty in continuously preventing neurohormonal overactivation and potential disadvan...
Autores principales: | Qiu, Zeping, Zhao, Jingwen, Huang, Fanyi, Bao, Luhan, Chen, Yanjia, Yang, Ke, Cui, Wenguo, Jin, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355140/ https://www.ncbi.nlm.nih.gov/pubmed/34376690 http://dx.doi.org/10.1038/s41536-021-00154-y |
Ejemplares similares
-
rhACE2 Therapy Modifies Bleomycin-Induced Pulmonary Hypertension via Rescue of Vascular Remodeling
por: Rathinasabapathy, Anandharajan, et al.
Publicado: (2018) -
RhACE2 – playing an important role in inhibiting apoptosis induced by Ang II in HUVECs
por: Zhang, Hongli, et al.
Publicado: (2019) -
Association and pharmacological synergism of the triple drug therapy baricitinib/remdesivir/rhACE2 for the management of COVID-19 infection
por: Vitiello, Antonio, et al.
Publicado: (2021) -
Combination of C21 and ARBs with rhACE2 as a therapeutic protocol: A new promising approach for treating ARDS in patients with coronavirus infection
por: Soheili, Marzieh, et al.
Publicado: (2020) -
Treatment Options Available for COVID-19 and an Analysis on Possible Role of Combination of rhACE2, Angiotensin (1-7) and Angiotensin (1-9) as Effective Therapeutic Measure
por: Muslim, Shahnawaz, et al.
Publicado: (2020)